American HealthCare Capital is pleased to introduce a multi-specialty research facility for sale in Florida. The facility is currently focused on Nonalcoholic steatohepatitis (NASH) screening leading to in house clinical trial research for Fatty Liver Disease. They currently contract with a national CRO and have developed a streamlined process to recruit, screen, and perform clinical research trials for their pharmaceutical sponsor.
The facility has been operational and seeing patients since February of 2022. They are actively licensed with AHCA for Biomedical waste and have a CLIA Certificate of Waiver. They have 2 employees and 4 contractors, all of whom are expected to stay on under new ownership. The seller is open to staying on a limited basis.
All reasonable offers will be considered.
If you would like to learn more, please use the form on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code and Listing Title from the summary above to complete the NDA.